SCHEMBL30793677

SCHEMBL30793677

CC(C)(C)OC(=O)N1CCCn2nc(C(=O)O)c(O)c2C1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ ESR2 Q92731 1/20 0.38
▸ ADORA1 P30542 1/20 0.38
▸ HPGD P15428 1/20 0.36
▸ CKS1B P61024 1/20 0.36
▸ SKP1 P63208 1/20 0.36
▸ SKP2 Q13309 1/20 0.36
▸ USP2 O75604 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ CYBB P04839 1/20 0.35
▸ NOX5 Q96PH1 1/20 0.35
▸ NOX4 Q9NPH5 1/20 0.35
▸ NOX1 Q9Y5S8 1/20 0.35
▸ NR1H2 P55055 2/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ FEN1 P39748 1/20 0.35
▸ GPR119 Q8TDV5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30793378 0.88 NR1H2 (0.43) MEN1KMT2AESR2HPGDUSP2
SCHEMBL25336741 0.88 MEN1 (0.38) MEN1KMT2AESR2ADORA1HPGD
SCHEMBL30793809 0.87 MEN1 (0.36) MEN1KMT2AESR2HPGDCKS1B
SCHEMBL30793460 0.86 MEN1 (0.38) MEN1KMT2AESR2ADORA1HPGD
SCHEMBL25335687 0.86 MEN1 (0.43) MEN1KMT2AESR2ADORA1HPGD
SCHEMBL30793341 0.86 MEN1 (0.38) MEN1KMT2AESR2ADORA1HPGD
SCHEMBL30793750 0.85 ADORA1 (0.39) MEN1KMT2AESR2ADORA1HPGD
SCHEMBL30793790 0.85 ADORA1 (0.43) MEN1KMT2AESR2ADORA1HPGD
SCHEMBL30793364 0.84 CKS1B (0.36) MEN1KMT2AESR2ADORA1HPGD
SCHEMBL30793426 0.84 MEN1 (0.39) MEN1KMT2AESR2ADORA1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4540254-A1 TETRAHYDROPYRIDOPYRIMIDINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2025-04-23 — — EP disclosed
WO-2023244604-A1 TETRAHYDROPYRIDOPYRIMIDINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2023-12-21 — — WO disclosed
Send feedback